The expression patterns of CD44 and CD45RB on peripheral blood T lymphocytes in the rejection of allogeneic murine skin transplantation

Transplant Immunology

Volumn 11, Issue 2, 2003, Pages 197-206

  Yang, Jaeseok ^a   Ahn, Curie ^a   Jung, Hee Kyeong ^a   Kim, Eun Kyeong ^a   Kim, Jae Young ^a   Kim, Yon Su ^a   Han, Jin Suk ^a   Kim, Suhnggwon ^a   Lee, Jung Sang ^a  

^a Seoul National University   (South Korea)

Author keywords

CD44; Peripheral blood T lymphocyte; Transplantation rejection

Indexed keywords

CD3 ANTIGEN; CD4 ANTIGEN; CD45 ANTIGEN; CD8 ANTIGEN; CELL MARKER; HERMES ANTIGEN; MEMBRANE ANTIGEN; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY CD3;

ALLOTRANSPLANTATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; EARLY DIAGNOSIS; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTER; FOLLOW UP; GRAFT REJECTION; GRAFT SURVIVAL; LYMPHOCYTE COUNT; MOUSE; NON INVASIVE MEASUREMENT; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; REPRODUCIBILITY; SAFETY; SCREENING TEST; SENSITIVITY AND SPECIFICITY; SKIN TRANSPLANTATION; STAINING; T LYMPHOCYTE ACTIVATION; TAIL;

ANIMALS; ANTIGENS, CD44; ANTIGENS, CD45; BIOLOGICAL MARKERS; FLOW CYTOMETRY; GRAFT REJECTION; GRAFT SURVIVAL; MICE; SKIN TRANSPLANTATION; T-LYMPHOCYTES; TRANSPLANTATION, HOMOLOGOUS; TRANSPLANTATION, ISOGENEIC;

EID: 0038714439     PISSN: 09663274     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0966-3274(03)00007-8     Document Type: Article

References (55)

1. Organ Transplantation Registry Committee, The Korean Society for Transplantation. Solid organ transplantation in Korea (1998). The Journal of the Korean Society for Transplantation 1999;13(2):185-194.
2. Koyama H, Cecka JM. Rejection episodes. Clin Transplant 1992;391-404.
3. Metas A, Gillingham KJ, Payne WD, Najarian JS. The impact of an acute rejection episode on long-term renal allograft survival (t1/2). Transplantation 1994;57:857-859.
4. Keil M, Pec MK, Schenn G, et al. Value of serum soluble tumour necrosis factor concentrations in the diagnosis and prognosis of renal graft rejection. Nephrol Dial Transplant 1994;9:815-819.
5. Grant SCD, Lamb WR, Hutchinson IV, Brenchley PEC. Serum soluble adhesion molecules and cytokines in cardiac allograft rejection. Transplant Immunol 1994;2:321-325.
6. Cattell EL, Cunningham AC, Bal W, Taylor RMR, Dark JH, Kirby JA. Limiting dilution analysis-quantification of IL-2 producing allospecific lymphocytes after renal and cardiac transplantation. Transplant Immunol 1994;2:300-307.
7. Van Der Woude FJ, Schrama E, Vanes SA, Claas FJH, Daha MR. The role of unconventional alloantigens in interstitial and vascular rejection after renal transplantation. Transplant Immunol 1994;2:271-277.
8. Manikkam S. Molecular analysis of human renal allograft: Differential intragraft gene expression during rejection. Kidney Int 1997;51(Suppl 58):S15-S21.
9. Pavlaskis M, Strehlau J, Lipman M, Shapiro M, Maslinski W, Strom TB. Intragraft IL-15 transcripts are increased in human renal allograft rejection. Transplantation 1996;62(4):543-545.
10. Toogood GJ, Rankin AM, Tam PK, Morris PJ, Dallman MJ. The immune response following small bowel transplantation: I. An unusual pattern of cytokine expression. Transplantation 1996;62(6):851-855.
11. Kirk AD, Bollinger RR, Finn OJ. Rapid, comprehensive analysis of human cytokine mRNA and its application to the study of acute renal allograft rejection. Hum Immunol 1995;43(2):113-128.
12. Krams SM, Falco DA, Villanueva JC, et al. Cytokine and T cell receptor gene expression at the site of allograft rejection. Transplantation 1992;53(1):151-156.
13. Stehlau J, Pavlakis M, Lipman M, et al. Quantitative detection of immune activation transcriptions as a diagnostic tool in kidney transplantation. Proc Natl Acad Sci USA 1997;94(2):695-700.
14. Legros-Maida S, Soulie A, Benvenuti C, et al. Granzyme B and perforin can be used as predictive markers of acute rejection in heart transplantation. Eur J Immunol 1994;24(1):229-233.
15. Griffiths GM, Namikawa R, Muller C, et al. Granzyme A and perforin as markers for rejection in cardiac transplantation. Eur J Immunol 1991;21(3):687-693.
16. Fuggle SV, Sanderson JB, Gray DW, Richardson A, Morris PJ. Variation in expression of endothelial adhesion molecules in pretransplant and transplant kidneys - Correlation with intragraft events. Transplantation 1993;55(1):117-123.
17. Brockmeyer C, Ulbrecht M, Schendel DJ, et al. Distribution of cell adhesion molecules (ICAM-1, VCAM-1, ELAM-1) in renal tissue during allograft rejection. Transplantation 1993;55(3):610-615.
18. Mampaso F, Sanchez-Madrid F, Marcen R, et al. Expression of adhesion molecules in allograft renal dysfunction. A distinct diagnostic pattern in rejection and cyclosporin nephrotoxicity. Transplantation 1993;56(3):687-691.
19. Hanson CA, Bolling SF, Stoolman LM, et al. Cytoimmunologic monitoring and heart transplantation. J Heart Transplant 1988;7(6):424-429.
20. McWhinnie DL, et al. Is the T4/T8 ratio an irrelevance in renal transplantation monitoring? First international symposium on relevant immunological factors in clinical kidney transplantation, Heidelberg, FR Germany, Transplant Proc, 1985;17(6):2548.
21. Hancock WW, Thomson NM, Atkins RC. Composition of interstitial cellular infiltrate identified by monoclonal antibodies in renal biopsies of rejecting human renal allografts. Transplantation 1983;35(5):453-463.
22. Platt JL, Lebien TW, Michael AF. Interstitial mononuclear cell populations in renal graft rejection. J Exp Med 1982;155:17-30.
23. Roberti I, Reisman L, Burrows L, Lieberman KV. Urine cytology and urine flow cytometry in renal transplantation - A prospective double blind study. Transplantation 1995;59(4):495-500.
24. Roberti I, Panico M, Reisman L. Urine flow cytometry as a tool to differentiate acute allograft rejection from other causes of acute renal graft dysfunction. Transplantation 1997;64(5):731-734.
25. Helderman JH, Hernandez J, Sagalowsky A, et al. Confirmation of the utility of fine needle aspiration biopsy of the renal allograft. Kidney Int 1988;34:376-381.
26. Rogenberg A. Skin allograft rejection. In: Coligan JE, editor. Current Protocols in Immunology, vol. Wiley, 1991. p. 4.4.
27. Counce S, et al. Strong and weak histocompatibility gene differences in mice and their role in the rejection of homografts of tumor and skin. Ann Surg 1956;144:425-437.
28. Hall BM, Bishop GA, Annabelle F, Duggin GG, Horvath JS. Identification of the cellular subpopulations infiltrating rejecting cadaver renal allografts. Preponderance of the T4 subset of T cells. Transplantation 1984;37(6):564-570.
29. Mazaheri R, Stiller CR, Keown PA. Clinical leukocyte phenotyping by laser flow cytometry and monoclonal antibodies (immunocytometry) in renal transplantation. Diagn Immunol 1986;4(5):257-267.
30. Kiparski AV, Frei D, Fierz W, et al. The effect of rejection crises and immunosuppressive therapy on the lymphocyte subpopulations of patients after kidney transplantation. Klin Wochenschr 1990;68(8):408-414.
31. Rees JC, Lifton MA, Light JA. Changes in lymphocyte subset distribution and in the differential diagnosis of renal allograft dysfunction. J Clin Lab Anal 1989;3(4):222-231.
32. Nanni-Costa A, Vangelista A, Frasca GM, Stefoni S, Bonomini V. T-cell subsets in renal allograft recipients. Transplant Proc 1983;15(1):1176-1177.
33. Henry GH, James W, Patrick JD. Alterations in immunologic measurements in patients expressing early hepatic allograft rejection. Transplantation 1988;45(5):923-925.
34. Van Es A, Meyer CJ, Oljans PJ, Tanke HJ, Van Es LA. Mononuclear cells in renal allografts. Correlation with peripheral blood T lymphocyte subpopulations and graft prognosis. Transplantation 1984;37(2):134-139.
35. Sanders ME, Makgoba MW, Shaw S. Human naive and memory cells: Reinterpretation of helper-inducer and suppressor-inducer subsets. Immunol Today 1988;9(7-8):195-199.
36. Werfel T, Boeker M, Kapp A. Rapid expression of the CD69 antigen on T cells and natural killer cells upon antigenic stimulation of peripheral blood mononuclear cell suspensions. Allergy 1997;52:465-469.
37. Caruso A, Licenziati S, Corulli M, et al. Flow cytometric analysis of activation markers on stimulated T cells and their correlation with cell proliferation. Cytometry 1997;27(1):71-76.
38. Doreen AC, Kendall AS. Transient expression of interleukin 2 receptors, consequence for T cell growth. J Exp Med 1983;158:1895-1911.
39. Beik AI, Bateman WJ, Morris AG, Higgins RM, Lam FT. Monitoring of T lymphocyte subsets in acute renal allograft rejection. Transplant Proc 1998;30:168-171.
40. Siegel DL, Fox I, Dafoe DC, et al. Discriminating rejection from CMV infection in renal allograft recipients using flow cytometry. Clin Immunol Immunopathol 1989;51(2):157-171.
41. Ciniti P, Evangelista B, Speziale A, et al. Comparative flow cytometry analysis of peripheral blood, graft infiltrating and urinary sediment cells during kidney allograft rejection. Transplant Proc 1995;27(1):919-921.
42. Ralph CB, Jean-Charles C, Clotilde H, et al. Distinction of virgin and memory T lymphocytes. J Immunol 1987;10(138):3120-3129.
43. William TL, Ellen SV. The differential expression of homing and adhesion molecules on virgin and memory T cells in the mouse. Cell Immunol 1991;132;215-222.
44. Susan LS, Linda MB, Michael C, et al. Helper T-cell subsets: Phenotype, function and the role of lymphokines in regulating their development. Immunol Rev 1991;123:115-144.
45. Buhrer C, Berlin C, Thiele HG, Hamann A. Lymphocyte activation and expression of the human leukocyte-endothelial cell activation molecule 1 (Leu-8/TQ1 antigen). Immunology 1990;71:442-448.
46. Battochio A, Solez K, Poppema S, Cockfield S, Rayner D. CD45 isoforms and lymphocyte activation antigens in acute renal allograft rejection. Transplant Proc 1996;28(1):482-483.
47. Ibrahim S, Dawson DV, Sanfilippo F. Predominant infiltration of rejecting human renal allografts with T cells expressing CD8 and CD45RO. Transplantation 1995;59(5):724-728.
48. Stein-Oakley AN, Kerr PG, Kraft NE, Atkins RC, Thomson NM. Phenotypic definition of primed T cells in human renal allografts. Use of the CD45R marker. Transplantation 1989;48(5):787-790.
49. Stephan NW, Christine W, Uwe R, Renate F, Margot Z, Manfred G. Predominant expression of CD44 splice variant v10 in malignant and reactive human skin lymphocytes. J Invest Dermatol 1998;111(3):464-471.
50. Simone S, Dirk S, Wolfgang T, Margot Z. CD44 variant isoform expression in a variety of skin-associated autoimmune diseases. Clin Immunol Immunopathol 1998;89(1):79-93.
51. Simone S, Bernd W, Wolfgang T, Margot Z. Down-modulation of host reactivity by anti-CD44 in skin transplantation. Transplantation 1998;66(6):778-791.
52. Aruna S, Lisa G, Mitzi N, Prakash SN. T-cell-receptor-independent activation of cytolytic activity of cytotoxic T lymphocytes mediated through CD44 and gp90MEL-14. Proc Natl Acad Sci USA 1991;88:7877-7881.
53. Uff CR, Reid SD, Wood Richard FM, Pockley AG. CD44 expression in rejecting rat small bowel allografts. Transplantation 1995;60(9):985-989.
54. Krishman R, Kireta S, Carter JK , Grooby WL, Rao MM, Russ GR. Expression of alternatively spliced CD44 mRNA in sheep renal allografts. Transplant Proc 1995;27(3):2170-2171.
55. Wells A, Larsson E, Hanas E, Laurent T, Hallgren R, Tufveson G. Increased hyaluronan in acutely rejecting human kidney grafts. Transplantation 1993;55(6):1346-1349.